For more than five decades, the ASH annual meeting has served as the premier event for scientific exchange in the field of hematology. Today, this meeting attracts more than 20,000 attendees from all over the world.
Since 2006, the IMF has provided a unique opportunity for support group leaders to attend ASH. This year we will be bringing 15 leaders from all over the US to share their ASH experience through blogs, Twitter, Facebook, and with their local communities at home. Our days will be long and challenging, but I am sure we will be invigorated by the excitement and hope of all this promising research!
This year is shaping up to be one of the biggest year’s ever for multiple myeloma. Dr. Durie and IMF Medical Editor, Debbie Birns, have selected a combination of research and clinically important topics for support group leaders to attend. Quite a task, as there are a total of 798 abstracts dealing with myeloma this year!
To wet your appetites, each leader is writing a “Pre-ASH blog” on what they are most looking forward to learning and sharing. Remember, these leaders are also myeloma patients and caregivers, so their perspective on the various abstracts, and living with myeloma, will certainly resonate with you.
In order for our IMF ASH 2015 Support Group Leader Team to provide you with a broad picture of ASH, each leader has selected topics to report on that are of particular interest to them. Please read their Pre-ASH blogs to get to know them and their interests.
Please also follow us on Twitter (#IMFASH15), each of us has a Twitter name listed under our picture and bio. We will be tweeting live and posting pictures from each of the below programs:
- IMF’s Satellite Symposium: “Global Advances in Myeloma: Providing Best Options for Treatment in 2015”
- Scientific Program: “Path Toward Curing Multiple Myeloma”
- Education Session: “Multiple Advances in Myeloma”
- IMF’s Grant Awards Reception
- Buetler Lecture: “Understanding the Proteasome”
- IMWG Live Conference Series: “Making Sense of Treatment”
- Simultaneous and Overlapping Oral Abstracts (eight of which were pre-selected by the ASH myeloma committee as “2016 Highlights of ASH”)
That’s it for now, stay tuned for your dose of daily hope!
Follow Robin on Twitter: @IMFsupport
Connecticut Multiple Myeloma Fighters Information Group